Cargando…
Inhalative Nanoparticulate CpG Immunotherapy in Severe Equine Asthma: An Innovative Therapeutic Concept and Potential Animal Model for Human Asthma Treatment
SIMPLE SUMMARY: Severe equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form), which is associated with exposure to hay dust and mold spores, has certain similarities to human asthma, and continues to represent a ther...
Autores principales: | Klier, John, Fuchs, Sebastian, Winter, Gerhard, Gehlen, Heidrun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405334/ https://www.ncbi.nlm.nih.gov/pubmed/36009677 http://dx.doi.org/10.3390/ani12162087 |
Ejemplares similares
-
A comparison of nanoparticullate CpG immunotherapy with and without allergens in spontaneously equine asthma‐affected horses, an animal model
por: Klier, John, et al.
Publicado: (2017) -
Nanoparticulate CpG Immunotherapy in RAO‐Affected Horses: Phase I and IIa Study
por: Klier, J., et al.
Publicado: (2015) -
Metalloproteinases and their Inhibitors under the Course of Immunostimulation by CPG-ODN and Specific Antigen Inhalation in Equine Asthma
por: Barton, Ann Kristin, et al.
Publicado: (2019) -
Immunomodulatory asthma therapy in the equine animal model: A dose‐response study and evaluation of a long‐term effect
por: Klier, John, et al.
Publicado: (2019) -
Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?
por: Barton, Ann Kristin, et al.
Publicado: (2016)